SCRO

Executive Summary

SCRO (Aurevia) is a Sweden-based clinical research organization (CRO) and regulatory consulting firm serving pharmaceutical, biotechnology, and medical technology clients. Founded in 2018, the company specializes in accelerating product development and achieving regulatory milestones for advanced therapy medicinal products (ATMPs), biologics, medical devices, and in-vitro diagnostics (IVDs). By leveraging deep industry expertise, SCRO delivers tailored, quality-assured solutions across the entire product lifecycle. As a private consulting firm with no disclosed funding or financials, its revenue is generated through project-based client engagements. Despite its small scale, SCRO benefits from the growing demand for specialized CRO services in Europe, particularly in the ATMP and medtech sectors. The company's Swedish base provides access to a robust life sciences ecosystem. However, without public pipeline data or significant media coverage, the visibility of near-term growth catalysts is limited.

Upcoming Catalysts (preview)

• H2 2026Expansion into ATMP Regulatory Services70% success
• TBDPartnership with a Major Biotech Client60% success
• 2026EU Regulatory Harmonization for Medtech80% success